Lorcaserin Extended-Release Tablets and Paclitaxel Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Paclitaxel Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Paclitaxel Novaplus
- Lorcaserin Extended-Release Tablets-Paclitaxel protein-bound
- Lorcaserin Extended-Release Tablets-Paclitaxel protein-bound Intravenous
- Lorcaserin Extended-Release Tablets-Pacnex
- Lorcaserin Extended-Release Tablets-Pacnex LP
- Lorcaserin Extended-Release Tablets-Pacnex MX
- Paclitaxel Intravenous-Lorcaserin Hydrochloride
- Paclitaxel Intravenous-Lorcaserin Tablets
- Paclitaxel Intravenous-Lorcet
- Paclitaxel Intravenous-Lorcet Plus
- Paclitaxel Intravenous-Lorcet Tablets
- Paclitaxel Intravenous-Lorlatinib